Evidence map›Paper›PMID 37621435›Full record

ArticleChemical science2023

Parallel multi-droplet platform for reaction kinetics and optimization.

Natalie S Eyke, Timo N Schneider, Brooke Jin, Travis Hart, Sebastien Monfette, Joel M Hawkins, Peter D Morse, Roger M Howard, David M Pfisterer, Kakasaheb Y Nandiwale and 1 more

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Natalie S EykeDepartment of Chemical Engineering, Massachusetts Institute of Technology Cambridge MA 02139 USA kfensen@mit.edu.ORCID https://orcid.org/0000-0003-1864-6857
Timo N SchneiderDepartment of Chemical Engineering, Massachusetts Institute of Technology Cambridge MA 02139 USA kfensen@mit.edu.
Brooke JinDepartment of Chemical Engineering, Massachusetts Institute of Technology Cambridge MA 02139 USA kfensen@mit.edu.
Travis HartDepartment of Chemical Engineering, Massachusetts Institute of Technology Cambridge MA 02139 USA kfensen@mit.edu.
Sebastien MonfettePfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.ORCID https://orcid.org/0000-0002-8394-4423
Joel M HawkinsPfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.
Peter D MorsePfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.
Roger M HowardPfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.
David M PfistererPfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.
Kakasaheb Y NandiwalePfizer Worldwide Research and Development 445 Eastern Point Rd Groton CT 06340 USA.ORCID https://orcid.org/0000-0002-0754-7362
Klavs F JensenDepartment of Chemical Engineering, Massachusetts Institute of Technology Cambridge MA 02139 USA kfensen@mit.edu.ORCID https://orcid.org/0000-0001-7192-580X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present an automated droplet reactor platform possessing parallel reactor channels and a scheduling algorithm that orchestrates all of the parallel hardware operations and ensures droplet integrity as well as overall efficiency. We design and incorporate all of the necessary hardware and software to enable the platform to be used to study both thermal and photochemical reactions. We incorporate a Bayesian optimization algorithm into the control software to enable reaction optimization over both categorical and continuous variables. We demonstrate the capabilities of both the preliminary single-channel and parallelized versions of the platform using a series of model thermal and photochemical reactions. We conduct a series of reaction optimization campaigns and demonstrate rapid acquisition of the data necessary to determine reaction kinetics. The platform is flexible in terms of use case: it can be used either to investigate reaction kinetics or to perform reaction optimization over a wide range of chemical domains.

Identifiers

PMID37621435
PMCPMC10445457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.